Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-07
1996-04-16
Siegal, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
055083013
ABSTRACT:
The present invention concerns compounds of formula (I) which is the novel 2-(1-pyrrolidinyl)ethylester of (.+-.)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxyl- or ketorolac-acid, the pharmaceutically acceptable addition salts thereof, preferably oxalate. It is known that the commercially available ketorolac (trometamole salt) exhibits undesired side effects (gastro-intestinal irritation and ulceration). Surprisingly, when applying the compounds according to the invention there are considerably less undesired effects which render them potentially of great advantage as analgetic/antiphlogistic agent.
REFERENCES:
patent: 4089969 (1978-05-01), Muchowski et al.
Lombardino, "Nonsteroidal Antiinflammatory Drugs." Otterness and Bliven, Chapter 3, pp. 228-231. John Wiley and Sons (1985).
The Merck index, Merck & Co., Inc., pp. 836, No. 5186 (1989).
"Salts of Four Analgesic/Antiinflammatory Agents with the Sodium Salts and the Free Acids." Pharmaceutical Research, vol. 2, No. 3, pp. 255-257 (1987).
Muchowski et al., "Synthesis and Antiinflammatory and Analgesic Activity of 5-Aroyl-1, 2-dihydro-3H-pyrrolo[1, 2-a]pyrrole-1-carboxylic Acids and Related Compounds," J. med. Chem., vol. 28, pp. 1037-1049 (1985).
Gu et al., "Preformulation Salt Selection, Physical Property Comparisons of the Tris(hydroxymethyl)aminomethane" (THAM) (1984).
Aldoma Gustavo Enrique
Monti Carlos E. A.
Roemmers S.A.I.C.F.
Siegal Alan
LandOfFree
Ketorolac derivatives with considerably reduced gastro-intestina does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ketorolac derivatives with considerably reduced gastro-intestina, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ketorolac derivatives with considerably reduced gastro-intestina will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-325456